Geoffrey Dow Buys Shares of SXTP $SXTP
Key Points
- Geoffrey Dow bought 7,350 shares of 60 Degrees Pharmaceuticals, Inc. ($SXTP) worth $10,143.
- $SXTP last traded around $1.49.
Geoffrey Dow, President and CEO at 60 Degrees Pharmaceuticals, Inc. ($SXTP), bought 7,350 shares at an average price of $1.38, for a total transaction of $10,143. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.
60 Degrees Pharmaceuticals, Inc. ($SXTP) Stock
60 Degrees Pharmaceuticals, Inc. Earnings
Analysts Set New Price Targets
About 60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal and pneumocystis pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue fever. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. 60 Degrees Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Washington, District Of Columbia.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.